Mitchell A. Lazar
Mitchell A. Lazar
Willard and Rhoda Ware Professor of Diabetes and Metabolic Diseases, University of Pennsylvania
Verified email at pennmedicine.upenn.edu
Title
Cited by
Cited by
Year
The hormone resistin links obesity to diabetes
CM Steppan, ST Bailey, S Bhat, EJ Brown, RR Banerjee, CM Wright, ...
Nature 409 (6818), 307-312, 2001
65772001
Cofactor dynamics and sufficiency in estrogen receptor–regulated transcription
Y Shang, X Hu, J DiRenzo, MA Lazar, M Brown
Cell 103 (6), 843-852, 2000
18802000
Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen
CJ Phiel, F Zhang, EY Huang, MG Guenther, MA Lazar, PS Klein
Journal of Biological Chemistry 276 (39), 36734-36741, 2001
18452001
The many faces of PPARγ
M Lehrke, MA Lazar
Cell 123 (6), 993-999, 2005
14752005
Thyroid hormone receptors: multiple forms, multiple possibilities
MA Lazar
Endocrine reviews 14 (2), 184-193, 1993
12941993
Resistin is an inflammatory marker of atherosclerosis in humans
MP Reilly, M Lehrke, ML Wolfe, A Rohatgi, MA Lazar, DJ Rader
Circulation 111 (7), 932-939, 2005
12442005
Fusion proteins of the retinoic acid receptor-α recruit histone deacetylase in promyelocytic leukaemia
F Grignani, S De Matteis, C Nervi, L Tomassoni, V Gelmetti, M Cioce, ...
Nature 391 (6669), 815-818, 1998
12441998
Forming functional fat: a growing understanding of adipocyte differentiation
AG Cristancho, MA Lazar
Nature reviews Molecular cell biology 12 (11), 722-734, 2011
11242011
International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors
L Michalik, J Auwerx, JP Berger, VK Chatterjee, CK Glass, FJ Gonzalez, ...
Pharmacological reviews 58 (4), 726-741, 2006
10722006
A unified nomenclature system for the nuclear receptor superfamily
J Auwerx, E Baulieu, M Beato, M Becker-Andre, PH Burbach, G Camerino, ...
Cell 97 (2), 161-163, 1999
10331999
Peroxisome proliferator-activated receptor (PPAR) gamma: adipose-predominant expression and induction early in adipocyte differentiation
A Chawla, EJ Schwarz, DD Dimaculangan, MA Lazar
Endocrinology 135 (2), 798-800, 1994
9981994
A novel therapy for colitis utilizing PPAR-γ ligands to inhibit the epithelial inflammatory response
CG Su, X Wen, ST Bailey, W Jiang, SM Rangwala, SA Keilbaugh, ...
The Journal of clinical investigation 104 (4), 383-389, 1999
9531999
Regulation of fasted blood glucose by resistin
RR Banerjee, SM Rangwala, JS Shapiro, AS Rich, B Rhoades, Y Qi, ...
Science 303 (5661), 1195-1198, 2004
9402004
A family of tissue-specific resistin-like molecules
CM Steppan, EJ Brown, CM Wright, S Bhat, RR Banerjee, CY Dai, ...
Proceedings of the National Academy of Sciences 98 (2), 502-506, 2001
9392001
Mechanisms of obesity-associated insulin resistance: many choices on the menu
M Qatanani, MA Lazar
Genes & development 21 (12), 1443-1455, 2007
9142007
New developments in adipogenesis
MI Lefterova, MA Lazar
Trends in Endocrinology & Metabolism 20 (3), 107-114, 2009
8372009
Differential activation of peroxisome proliferator-activated receptors by eicosanoids
K Yu, W Bayona, CB Kallen, HP Harding, CP Ravera, G McMahon, ...
Journal of Biological Chemistry 270 (41), 23975-23983, 1995
8371995
The mechanism of action of thyroid hormones
J Zhang, MA Lazar
Annual review of physiology 62, 2000
8192000
Enzymatic activity associated with class II HDACs is dependent on a multiprotein complex containing HDAC3 and SMRT/N-CoR
W Fischle, F Dequiedt, MJ Hendzel, MG Guenther, MA Lazar, W Voelter, ...
Molecular cell 9 (1), 45-57, 2002
8182002
Resistin and obesity-associated insulin resistance
CM Steppan, MA Lazar
Trends in endocrinology & Metabolism 13 (1), 18-23, 2002
7662002
The system can't perform the operation now. Try again later.
Articles 1–20